In-Depth Study of the Cancer Biomarkers Market: Size, Share, and Leading Company Profiles
Market Overview Global Cancer Biomarkers Market size and share is currently valued at USD 23.91 billion in 2024 and is anticipated to generate an estimated revenue of USD 69.05 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 11.2% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034 Cancer biomarkers are biological molecules found in blood, other body fluids, or tissues that signify the presence of cancer. They play a crucial role in early detection, risk assessment, and monitoring therapeutic responses. The increasing prevalence of cancer worldwide, coupled with the demand for non-invasive diagnostic techniques, has accelerated the adoption of biomarker-based tests. Technological advancements, particularly in genomics and proteomics, have enhanced the sensitivity and specificity of biomarker assays. The integration of artificial intelligence and machine lea...